Long-term results of deep sclerectomy with collagen implant
- PMID: 15177596
- DOI: 10.1016/j.jcrs.2003.10.035
Long-term results of deep sclerectomy with collagen implant
Abstract
Purpose: To study prospectively the success rate and complications of deep sclerectomy with collagen implant (DSCI).
Setting: Glaucoma Unit, Department of Ophthalmology, Hôpital Ophtalmique Jules Gonin, University of Lausanne, Lausanne, Switzerland.
Methods: This nonrandomized prospective trial comprised 105 eyes of 105 patients with medically uncontrolled primary and secondary open-angle glaucoma. Visual acuity, intraocular pressure (IOP), and slitlamp examinations were performed before surgery and after surgery at 1 and 7 days, and 1, 3, 6, 9, 12, 18, 24, 30, 36, 48, 54, 60, 66, 72, 78, 84, 90, and 96 months. Visual field examinations were repeated every 6 months.
Results: Mean follow-up period was 64 months +/- 26.6 (SD). Mean preoperative IOP was 26.8 +/- 7.7 mm Hg, and mean postoperative IOP was 5.2 +/- 3.35 mm Hg at day 1 and 12 +/- 3 mm Hg at month 78. At 96 months, the qualified success rate (ie, patients who achieved IOP <21 mm Hg with and without medication) was 91%, and the complete success rate (ie, IOP <21 mm Hg without medication) was 57%. At 96 months, 34% of patients had an IOP <21 mm Hg with medication. Fifty-one patients (49%) achieved an IOP < or =15 mm Hg without medication. Neodymium:YAG goniopuncture was performed in 54 patients (51%); mean time of goniopuncture performance was 21 months, and mean IOP before goniopuncture was 20 mm Hg, dropping to 11 mm Hg after goniopuncture. No shallow or flat anterior chamber, endophthalmitis, or surgery-induced cataract was observed. However, 26 patients (25%) showed a progression of preexisting senile cataract (mean time 26 months; range 18 to 37 months). Injections of 5-fluorouracil were administered to 25 patients (23%) who underwent DSCI to salvage encysted blebs. Mean number of medications per patient was reduced from 2.3 +/- 0.7 to 0.5 +/- 0.7 (signed rank P<.0001).
Conclusion: Deep sclerectomy with collagen implant appears to provide stable and reasonable control of IOP at long-term follow-up with few immediate postoperative complications.
Comment in
-
Long-term results of deep sclerectomy with collagen implant.J Cataract Refract Surg. 2005 May;31(5):868-9. doi: 10.1016/j.jcrs.2005.03.048. J Cataract Refract Surg. 2005. PMID: 15975441 No abstract available.
Similar articles
-
Five-year results of deep sclerectomy with collagen implant.J Cataract Refract Surg. 2001 Nov;27(11):1770-8. doi: 10.1016/s0886-3350(01)01032-x. J Cataract Refract Surg. 2001. PMID: 11709250 Clinical Trial.
-
Long-term results of deep sclerectomy with collagen implant in exfoliative glaucoma.J Glaucoma. 2009 Jun-Jul;18(5):361-7. doi: 10.1097/IJG.0b013e3181879e4e. J Glaucoma. 2009. PMID: 19525725
-
Deep sclerectomy in one eye vs deep sclerectomy with collagen implant in the contralateral eye of the same patient: long-term follow-up.Eye (Lond). 2005 Mar;19(3):298-302. doi: 10.1038/sj.eye.6701469. Eye (Lond). 2005. PMID: 15258610 Clinical Trial.
-
Indications and technique for reopening closed filtering blebs using the Nd:YAG laser--a review and case series.Ophthalmic Surg. 1993 Sep;24(9):617-22. Ophthalmic Surg. 1993. PMID: 8233337 Review.
-
Nonpenetrating deep sclerectomy: collagen implant and viscocanalostomy procedures.Int Ophthalmol Clin. 1999 Summer;39(3):103-19. doi: 10.1097/00004397-199903930-00010. Int Ophthalmol Clin. 1999. PMID: 10709577 Review. No abstract available.
Cited by
-
Nd:YAG laser goniopuncture in viscocanalostomy: penetration in non-penetrating glaucoma surgery.Int Ophthalmol. 2010 Jun;30(3):245-52. doi: 10.1007/s10792-009-9312-0. Epub 2009 May 29. Int Ophthalmol. 2010. PMID: 19479194
-
Plasma Rich in Growth Factors as an Adjuvant Agent in Non-Penetrating Deep Sclerectomy.J Clin Med. 2023 May 22;12(10):3604. doi: 10.3390/jcm12103604. J Clin Med. 2023. PMID: 37240710 Free PMC article.
-
Visual and surgical outcomes of MMC augmented combined non-penetrating deep sclerectomy and phacoemulsification in eyes with severe and end stage glaucoma.Eye (Lond). 2025 Jun;39(8):1571-1577. doi: 10.1038/s41433-025-03719-z. Epub 2025 Feb 21. Eye (Lond). 2025. PMID: 39979611
-
Deep sclerectomy with the Ex-PRESS X-200 implant for the surgical treatment of glaucoma.Int Ophthalmol. 2010 Dec;30(6):661-8. doi: 10.1007/s10792-010-9382-z. Epub 2010 Jun 16. Int Ophthalmol. 2010. PMID: 20552258
-
Phacoemulsification combined with deep sclerectomy augmented with mitomycin and amniotic membrane implantation in chronic primary open angle glaucoma with cataract.Electron Physician. 2016 Apr 25;8(4):2218-26. doi: 10.19082/2218. eCollection 2016 Apr. Electron Physician. 2016. PMID: 27279995 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources